Process for the Production of Peglated Staphylokinase (SAK)
Implementing Organization
Council of Scientific & Industrial Research, Extra Mural Research Division (CSIR-EMR), India
Project Overview
This invention relates to the production process of peglated staphylokinase (SAK) having extended plasma half-life and high stability. It is used as a clot bluster drug. PEGylated SAK derivatives have better potential for the efficient and cost-effective treatment of cardio-vascular diseases. As a clot bluster drug, SAK is considerably more fibrin-specific than streptokinase.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Council of Scientific & Industrial Research, Extra Mural Research Division (CSIR-EMR), India
Accessibility Controls